Literature DB >> 14984688

Orally administered sodium oxybate for the treatment of narcolepsy.

Michael Thorpy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14984688     DOI： 10.1007/s11910-004-0030-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  4 in total

1.  Current concepts in the etiology, diagnosis and treatment of narcolepsy.

Authors: 
Journal:  Sleep Med       Date:  2001-01       Impact factor: 3.492

2.  Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men.

Authors:  E Van Cauter; L Plat; M B Scharf; R Leproult; S Cespedes; M L'Hermite-Balériaux; G Copinschi
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

3.  A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.

Authors: 
Journal:  Sleep       Date:  2002-02-01       Impact factor: 5.849

4.  From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy.

Authors:  David E Fuller; Carl S Hornfeldt
Journal:  Pharmacotherapy       Date:  2003-09       Impact factor: 4.705
  4 in total
  1 in total

1.  Narcolepsy-cataplexy: how does recent understanding help in evaluation and treatment.

Authors:  Mujahid Mahmood; Jed Black
Journal:  Curr Treat Options Neurol       Date:  2005-09       Impact factor: 3.972
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.